196 related articles for article (PubMed ID: 25110239)
1. CAMTA1 immunostaining is not useful in differentiating epithelioid hemangioendothelioma from its potential mimickers.
Yusıflı Z; Kösemehmetoğlu K
Turk Patoloji Derg; 2014; 30(3):159-65. PubMed ID: 25110239
[TBL] [Abstract][Full Text] [Related]
2. Nuclear Expression of CAMTA1 Distinguishes Epithelioid Hemangioendothelioma From Histologic Mimics.
Doyle LA; Fletcher CD; Hornick JL
Am J Surg Pathol; 2016 Jan; 40(1):94-102. PubMed ID: 26414223
[TBL] [Abstract][Full Text] [Related]
3. CAMTA1 immunostaining is not useful in differentiating epithelioid hemangioendothelioma from its potential mimickers.
Wiwanitkit V
Turk Patoloji Derg; 2015; 31(1):80. PubMed ID: 25560612
[No Abstract] [Full Text] [Related]
4. Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics.
Sugita S; Hirano H; Kikuchi N; Kubo T; Asanuma H; Aoyama T; Emori M; Hasegawa T
Diagn Pathol; 2016 Aug; 11(1):75. PubMed ID: 27515856
[TBL] [Abstract][Full Text] [Related]
5. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.
Hung YP; Fletcher CD; Hornick JL
Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608
[TBL] [Abstract][Full Text] [Related]
6. CAMTA-1 Expression in 24 Cases of Hepatic Epithelioid Hemangioendothelioma in a Single Institute: Diagnostic Utility for Differential Diagnosis from Hepatic Angiosarcoma.
Jung H; Kim HN; Jang Y; Park CK; Ha SY
In Vivo; 2019; 33(6):2293-2297. PubMed ID: 31662570
[TBL] [Abstract][Full Text] [Related]
7. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites.
Errani C; Zhang L; Sung YS; Hajdu M; Singer S; Maki RG; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2011 Aug; 50(8):644-53. PubMed ID: 21584898
[TBL] [Abstract][Full Text] [Related]
8. Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements.
Lee SJ; Yang WI; Chung WS; Kim SK
Oncotarget; 2016 Feb; 7(7):7480-8. PubMed ID: 26840265
[TBL] [Abstract][Full Text] [Related]
9. CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma.
Shibuya R; Matsuyama A; Shiba E; Harada H; Yabuki K; Hisaoka M
Histopathology; 2015 Dec; 67(6):827-35. PubMed ID: 25879300
[TBL] [Abstract][Full Text] [Related]
10. Thoracic epithelioid malignant vascular tumors: a clinicopathologic study of 52 cases with emphasis on pathologic grading and molecular studies of WWTR1-CAMTA1 fusions.
Anderson T; Zhang L; Hameed M; Rusch V; Travis WD; Antonescu CR
Am J Surg Pathol; 2015 Jan; 39(1):132-9. PubMed ID: 25353289
[TBL] [Abstract][Full Text] [Related]
11. Epithelioid hemangioendothelioma with extensive cystic change and CAMTA1 rearrangement.
Lee SE; Park HY; Kim S; Bang H; Min JH; Choi YL
Pathol Int; 2013 Oct; 63(10):502-5. PubMed ID: 24134632
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants.
Patel NR; Salim AA; Sayeed H; Sarabia SF; Hollingsworth F; Warren M; Jakacky J; Tanas M; Oliveira AM; Rubin BP; Lazar AJ; López-Terrada D; Wang WL
Histopathology; 2015 Nov; 67(5):699-708. PubMed ID: 25817592
[TBL] [Abstract][Full Text] [Related]
13. Pleural epithelioid hemangioendothelioma harboring CAMTA1 rearrangement.
Ha SY; Choi IH; Han J; Choi YL; Cho JH; Lee KJ; Sun JM
Lung Cancer; 2014 Mar; 83(3):411-5. PubMed ID: 24461304
[TBL] [Abstract][Full Text] [Related]
14. Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets.
Rosenbaum E; Jadeja B; Xu B; Zhang L; Agaram NP; Travis W; Singer S; Tap WD; Antonescu CR
Mod Pathol; 2020 Apr; 33(4):591-602. PubMed ID: 31537895
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence
Yang P; Zhang S; Yu C; Yan W; Yang N; Li N; Huang Y; Chen H; Cai Z; Zhao Y; Qin Y; Gong X; Feng Z
Am J Transl Res; 2020; 12(8):4561-4568. PubMed ID: 32913529
[TBL] [Abstract][Full Text] [Related]
16. Epithelioid Hemangioendothelioma: a Rare Primary Thyroid Tumor with Confirmation of WWTR1 and CAMTA1 Rearrangements.
Shah AA; Ohori NP; Yip L; Coyne C; Antonescu CR; Seethala RR
Endocr Pathol; 2016 Jun; 27(2):147-52. PubMed ID: 27026033
[TBL] [Abstract][Full Text] [Related]
17. Multicentric visceral epithelioid hemangioendothelioma, with extremity dermal deposits, unusual late recurrence on the nasal bridge, and TFE3 gene rearrangement.
Thway K; Mentzel T; Perrett CM; Calonje E
Hum Pathol; 2018 Feb; 72():153-159. PubMed ID: 28855107
[TBL] [Abstract][Full Text] [Related]
18. Primary Intranodal Epithelioid Hemangioendothelioma with Molecular Confirmation.
Vazzano JL; Patton A; Tinoco G; Iwenofu OH
Int J Surg Pathol; 2022 Aug; 30(5):557-563. PubMed ID: 35098778
[TBL] [Abstract][Full Text] [Related]
19. WWTR1(TAZ)-CAMTA1 reprograms endothelial cells to drive epithelioid hemangioendothelioma.
Driskill JH; Zheng Y; Wu BK; Wang L; Cai J; Rakheja D; Dellinger M; Pan D
Genes Dev; 2021 Apr; 35(7-8):495-511. PubMed ID: 33766984
[TBL] [Abstract][Full Text] [Related]
20. Cytologic features and immunohistochemical findings of epithelioid hemangioendothelioma (EHE) in effusion: A case series.
Jebastin Thangaiah J; Hanley K; Nomani L; Policarpio-Nicolas ML
Diagn Cytopathol; 2021 Jan; 49(1):E24-E30. PubMed ID: 32797671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
